SCHEMBL839538

SCHEMBL839538

Fc1ccc(Br)nc1CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18397344 0.82
SCHEMBL18132263 0.80 LOXL2 (0.32)
SCHEMBL1864095 0.80 KDM4E (0.32)
SCHEMBL13082139 0.80 CCR4 (0.30)
SCHEMBL16466314 0.77 TRPV3 (0.31)
SCHEMBL24742198 0.76 CCR1 (0.31)
SCHEMBL15243578 0.76 TRPV3 (0.31)
SCHEMBL18640593 0.76 KDM4E (0.41)
SCHEMBL3869526 0.75 CTSL (0.32)
SCHEMBL1506555 0.73 S1PR4 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4624474-A1 PHARMACEUTICALLY ACCEPTABLE SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2025-10-01 EP disclosed
US-20250296939-A1 BENZOTHIOPHENE COMPOUND KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2025-09-25 US disclosed
WO-2025092973-A1 PARP1-TARGETING COMPOUND AND USE THEREOF 成都赜灵生物医药科技有限公司 2025-05-08 WO disclosed
US-12275726-B2 Aurora kinase inhibitors and use thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2025-04-15 US disclosed
WO-2025067417-A1 FUSED LACTAM RING COMPOUND AND USE THEREOF 成都赜灵生物医药科技有限公司 2025-04-03 WO disclosed
EP-4516792-A1 BENZOTHIOPHENE COMPOUND Kyoto Pharmaceutical Industries, Ltd. (JP) 2025-03-05 EP disclosed
WO-2024255697-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND MEDICAL USE THEREOF 中国医药研究开发中心有限公司 2024-12-19 WO disclosed
US-20240287094-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINES JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2024-08-29 US disclosed
WO-2024109871-A1 PHARMACEUTICALLY ACCEPTABLE SALT OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, CRYSTAL FORM THEREOF, AND PREPARATION METHOD THEREFOR 江苏恒瑞医药股份有限公司 2024-05-30 WO disclosed
EP-4349836-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINES Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2024-04-10 EP disclosed
WO-2016077161-A1 AURORA A KINASE INHIBITOR ELI LILLY AND COMPANY (US) 2016-05-19 WO disclosed
US-20160137628-A1 Aurora A Kinase Inhibitor ELI LILLY AND COMPANY 2016-05-19 US disclosed
US-8466176-B2 Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE AG (DE) 2013-06-18 US disclosed
US-8143246-B2 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives MSD OSS B.V. (NL) 2012-03-27 US disclosed
EP-2373639-A1 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES N.V. Organon (NL) 2011-10-12 EP disclosed
US-20110105566-A1 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2011-05-05 US disclosed
EP-2265118-A2 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES Bayer CropScience AG (DE) 2010-12-29 EP disclosed
US-20100144724-A1 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES N.V.ORGANON 2010-06-10 US disclosed
WO-2010063666-A1 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES N.V. ORGANON (NL) 2010-06-10 WO disclosed
WO-2009115557-A2 FUNGICIDE HYDROXIMOYL-TETRAZOLE DERIVATIVES BAYER CROPSCIENCE SA (FR) 2009-09-24 WO disclosed